Incidence Of Epiretinal Membranes After Phacoemulsification With Implantation Of An Intraocular Lens - The Erm Phaco Trial
Published 2024 - 42nd Congress of the ESCRS
Reference: PO398 | Type: Poster | DOI: 10.82333/p9f7-8w56
Authors: Nikolaus Hommer* 1 , Manuel Ruiss 1 , Caroline Pilwachs 1 , Natascha Bayer 1 , Stefan Georgiev 1 , Andreas Schlatter 1 , Andrea Fisus 1 , Victoria Kauer 1 , Leon Pomberger 2 , Oliver Findl 1 , Christoph Leisser 1
1Department of Ophthalmology, VIROS - Vienna Institute for Research in Ocular Surgery,Hanusch Hospital,Vienna,Austria, 2Department of Ophthalmology,Johannes Kepler University,Linz,Austria
Purpose
The aim of the present study was to investigate the incidence of development of new ERM (epiretinal membrane) after phacoemulsification with implantation of an intraocular lens (IOL)
Setting
Methods
This prospective case control study aimed to examine the incidence of development of new ERM after phacoemulsification with implantation of an IOL, and to record postoperative best corrected visual acuity. Additionally, possible risk factors for development of ERM after surgery were examined using OCT (optical coherence tomography) outcomes. Two separate examiners conducted assessments of the OCT examinations. A total of 94 participants completed the final follow-up. All study participants underwent a pre-study screening including ophthalmic examination, macular OCT (Spectralis, Heidelberg Engineering, Germany) and visual acuity. Approximately one year post-surgery, identical examinations were conducted.
Results
94 patients have successfully completed the study. However, as the data analysis remains ongoing, final results will be presented at the conference.
Conclusions
Since we haven't obtained any results yet, we're unable to formulate any conclusions at this point. The conclusions will be presented at the conference.